← back to search

Verena Keitel

University of Michigan–Ann Arbor · US
🔎 Find collaborators in Oncology · Surgery →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Oncology · Surgery
Research interest
Research focused on Cholestasis and Hepatocyte, with related work in Primary sclerosing cholangitis, Immunology, Carcinogenesis. Notable publications include 'Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms...', 'Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19', and 'Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS'.
h-index
citations
2,816
works
24
NIH funding
primary concept
email

Recent publications

Cell type specific decoding of TGF-β2 production, signaling and outcome in the dynamics of cholestatic liver disease
Zeitschrift für Gastroenterologie 2025cited by 0position: middledoi
Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)
Infection 2024cited by 12position: middledoi
Systematic assessment of COVID-19 host genetics using whole genome sequencing data
PLoS Pathogens 2024cited by 1position: middledoi
Sublethal necroptosis signaling promotes inflammation and liver cancer
Immunity 2023cited by 131position: middledoi
Semaphorin 3C exacerbates liver fibrosis
Hepatology 2023cited by 23position: middledoi
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC)
BMC Cancer 2023cited by 4position: middledoi
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience
Cancers 2022cited by 24position: middledoi
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases – The PARLIM trial (AIO KRK 0314)
European Journal of Cancer 2022cited by 11position: middledoi
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19
Immunity 2021cited by 257position: middledoi
Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis
Journal of Hepatology 2021cited by 111position: lastdoi
Diagnosis and management of secondary causes of steatohepatitis
Journal of Hepatology 2021cited by 106position: lastdoi
Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH
Cellular and Molecular Gastroenterology and Hepatology 2021cited by 16position: middledoi
JNK signaling prevents biliary cyst formation through a CASPASE-8–dependent function of RIPK1 during aging
Proceedings of the National Academy of Sciences 2021cited by 14position: middledoi
IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression
Journal of Hepatology 2020cited by 37position: middledoi
Bile Microinfarcts in Cholestasis Are Initiated by Rupture of the Apical Hepatocyte Membrane and Cause Shunting of Bile to Sinusoidal Blood
Hepatology 2018cited by 101position: middledoi
Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset
Hepatology Communications 2018cited by 94position: middledoi
Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice
Gastroenterology 2018cited by 37position: middledoi
Cholestasis induced liver pathology results in dysfunctional immune responses after arenavirus infection
Scientific Reports 2018cited by 7position: middledoi
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS
Cancer Cell 2017cited by 195position: middledoi
Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants
Journal of Hepatology 2017cited by 135position: lastdoi
Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family
PLoS ONE 2016cited by 16position: middledoi
Bile salt export pump‐reactive antibodies form a polyclonal, multi‐inhibitory response in antibody‐induced bile salt export pump deficiency
Hepatology 2015cited by 51position: middledoi
Characterization of animal models for primary sclerosing cholangitis (PSC)
Journal of Hepatology 2014cited by 162position: middledoi
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Archives of Toxicology 2013cited by 1,271position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dieter Häussinger · Heinrich Heine University Düsseldorf4 papers (2015–2018)Tom Luedde · Heinrich Heine University Düsseldorf3 papers (2021–2023)Maria Reich · University Hospital Magdeburg3 papers (2020–2025) · 3 papers (2015–2018)Eva‐Doreen Pfister · Medizinische Hochschule Hannover2 papers (2017–2018)Raphael Mohr · Charité - Universitätsmedizin Berlin2 papers (2022–2023)Ulrich Baumann · Medizinische Hochschule Hannover2 papers (2017–2018)Christian Trautwein · FH Aachen2 papers (2018–2023)Ulrich Baumann · Medizinische Hochschule Hannover2 papers (2015–2021)Frank Lammert · Medical University of Warsaw2 papers (2018–2018)Mathias Heikenwälder · German Cancer Research Center2 papers (2021–2023) · 2 papers (2015–2017)Christoph Schramm · J.M. Huber Corporation (United States)2 papers (2014–2020) · 2 papers (2015–2021) · 2 papers (2015–2017) · 2 papers (2022–2023)Mario Strazzabosco · Yale Cancer Center2 papers (2014–2020)Lutz Schmitt · University Hospital Heidelberg2 papers (2015–2017) · 2 papers (2015–2017)Dorothee Schwinge · Universität Hamburg2 papers (2020–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Surgery →